Abstract
Our understanding of the lymphatic vascular system lags far behind that of the blood vascular system, limited by available imaging technologies. We present a label-free optical imaging method that visualizes the lymphatic system with high contrast. We developed an orthogonal polarization imaging (OPI) in the shortwave infrared range (SWIR) and imaged both lymph nodes and lymphatic vessels of mice and rats in vivo through intact skin, as well as human mesenteric lymph nodes in colectomy specimens. By integrating SWIR-OPI with U-Net, a deep learning image segmentation algorithm, we automated the lymph node size measurement process. Changes in lymph nodes in response to cancer progression were monitored in two separate mouse cancer models, through which we obtained insights into pre-metastatic niches and correlation between lymph node masses and many important biomarkers. In a human pilot study, we demonstrated the effectiveness of SWIR-OPI to detect human lymph nodes in real time with clinical colectomy specimens.
Introduction
The lymphatic system serves as a critical highway for cancer metastasis, yet imaging it remains a significant challenge. Current clinical standards, such as CT, MRI, and ultrasound, often struggle to distinguish lymph nodes from surrounding adipose tissue due to low spatial resolution or poor tissue contrast. While optical imaging offers higher resolution, it typically relies on exogenous contrast agents like Indocyanine Green (ICG). These dyes can be invasive, potentially alter physiological measurements, and may fail to highlight nodes if lymphatic vessels are obstructed by tumors. This research presents a "label-free" solution that leverages the intrinsic chemical properties of lymphatic tissue.
Methods: SWIR-OPI and Deep Learning
To address these limitations, the researchers developed Shortwave Infrared Orthogonal Polarization Imaging (SWIR-OPI). This system utilizes 1550 nm light, a wavelength that experiences significantly less scattering in biological tissue compared to visible or near-infrared light.
The hardware and software integration includes:
- SWIR-OPI Hardware: By employing cross-polarized filters, the system blocks surface glare and shallowly back-scattered photons, capturing light that has penetrated deeper into the tissue.
- Telecentric Imaging: A custom object-space telecentric lens ensures constant magnification regardless of subject distance, which is vital for longitudinal tracking of lymph node size in living models.
- U-Net Segmentation: To handle the high volume of data (over 500,000 images), the team implemented a 6-level U-Net architecture. This deep learning model automates the segmentation of lymph nodes and calculation of their surface area, enabling high-throughput analysis.
Key Insights: The Physics of Contrast
The high contrast observed in SWIR-OPI is driven by two primary factors: water absorption and polarization retention. Lymphatic structures are water-rich, whereas surrounding fat is relatively dry. At 1550 nm, water absorbs light strongly, causing lymph nodes and vessels to appear dark against a bright fatty background.
As shown in the penetration studies, longer wavelengths like 1550 nm retain their polarization state much better than shorter wavelengths as they travel through tissue. Interestingly, blood vessels do not appear as dark as lymphatics despite their high water content. This is due to intense scattering from red blood cells that "fills in" the absorption signal, making the technique highly specific to the lymphatic system.
Results and Clinical Potential
The system achieved a spatial resolution of 65 µm in vivo through intact mouse skin. In cancer models, the researchers detected lymph node expansion as early as four days post-implantation—well before the arrival of metastatic cells. This provides a window into the "pre-metastatic niche," where tumors prime distant nodes for future colonization. Lymph nodes destined for metastasis grew by up to 130% in area, compared to a maximum of 65% for non-metastatic nodes.
Furthermore, changes in lymph node size correlated strongly with tumor biomarkers such as PD-L1, suggesting that monitoring these nodes could serve as a non-invasive proxy for a tumor's immune status. In a pilot study with human colectomy specimens, SWIR-OPI successfully identified lymph nodes buried in fat that were nearly invisible to the naked eye under standard white light, highlighting its potential as an intra-operative guidance tool for surgeons.
Summary updated